Tooth-Borne Versus Tooth-Bone-Borne Rapid Maxillary Expanders: A Stereophotogrammetric Evaluation of Soft Tissues
Launched by GÖKÇENUR GÖKÇE · Mar 31, 2021
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
Introduction: To evaluate the effects of tooth-borne and tooth-bone-borne rapid maxillary expansion (RME) on soft tissue with stereophotogrammetry. Methods: 32 patients (15 males, 17 females) who met inclusion criteria were divided into two groups. In the first group, tooth-borne RME appliance (Hyrax) was applied to 16 patients (9 males, 7 females mean age 13.4 ± 1.3 years) and in the second group, tooth-bone-borne RME appliance (Hybrid Hyrax) was applied to 16 patients (6 males, 10 females mean age 13.05 ±1.24 years). A simple electronically generated randomization was performed before tri...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. No previous tonsillar, nasal or adenoid surgery and orthodontic treatment,
- • 2. Bilateral crossbite and need for RME,
- • 3. Maxillary and mandibular permanent teeth fully erupted,
- • 4. Willingness to participate in the study
- Exclusion Criteria:
- • 1. the presence of adenotonsillectomy due to tonsillar hypertrophy or adenoidal hypertrophy
- • 2. Having nasal/nasopharyngeal /oropharyngeal pathologies, craniofacial syndromes, systemic disease, poor oral hygiene,
- • 3. History of previous orthodontic treatment.
About Gökçenur Gökçe
Gökçenur Gökçe is a dedicated clinical trial sponsor committed to advancing medical research and improving patient care through innovative and rigorous clinical studies. With a focus on ethical practices and compliance, Gökçe leads initiatives that explore new therapeutic options across various therapeutic areas. Leveraging a robust network of healthcare professionals and state-of-the-art methodologies, Gökçenur Gökçe fosters collaboration and transparency in the research process, ensuring that all trials are conducted with the highest standards of integrity and scientific excellence. Through its commitment to patient safety and data integrity, Gökçenur Gökçe aims to contribute meaningfully to the development of effective treatments and enhance the overall health outcomes in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials